Ryan Fukushima Sells 20,000 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 20,000 shares of Tempus AI stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $39.61, for a total value of $792,200.00. Following the completion of the transaction, the chief operating officer now owns 982,442 shares of the company’s stock, valued at approximately $38,914,527.62. The trade was a 2.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Ryan Fukushima also recently made the following trade(s):

• On Monday, December 16th, Ryan Fukushima sold 3,500 shares of Tempus AI stock. The shares were sold at an average price of $40.23, for a total transaction of $140,805.00.
• On Wednesday, December 11th, Ryan Fukushima sold 120,000 shares of Tempus AI stock. The stock was sold at an average price of $42.51, for a total value of $5,101,200.00.

Tempus AI Stock Performance

Tempus AI stock opened at $37.49 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $79.49. The firm’s fifty day simple moving average is $48.59 and its 200-day simple moving average is $46.96.

Institutional Trading of Tempus AI

A number of institutional investors and hedge funds have recently made changes to their positions in TEM. Pier Capital LLC bought a new stake in Tempus AI during the 2nd quarter valued at approximately $2,301,000. Federated Hermes Inc. bought a new stake in Tempus AI during the 2nd quarter worth about $19,886,000. Revolution Growth Management Company Inc. bought a new stake in shares of Tempus AI during the second quarter valued at approximately $128,133,000. Allen Operations LLC acquired a new stake in shares of Tempus AI in the 2nd quarter valued at $3,831,000. Finally, WINTON GROUP Ltd acquired a new stake in Tempus AI in the second quarter worth about $634,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on TEM. Piper Sandler restated a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Guggenheim began coverage on shares of Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Wolfe Research initiated coverage on Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective for the company. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and raised their target price for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Finally, Loop Capital raised their target price on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.